See the latest information and resources from Elrha in relation to coronavirus (Covid-19)

We are Elrha, a force for change in the humanitarian community. The research and innovation we support equips the humanitarian community with the knowledge of what works, so people affected by crises get the right help when they need it most.
Our purpose is clear: to empower the humanitarian community to improve humanitarian response. We make this happen by supporting and championing the outcomes of robust research and proven innovations.
We empower the humanitarian community. Find out how we can support you...

Principal Investigators: Stefan Flasche, LSHTM & Francesco Checci, LSHTM

Purpose

The study aims to identify effective and cost-effective pneumococcal vaccination strategies for crisis affected
populations. Specifically, the research will:

  1. identify optimal mass pneumococcal vaccination strategies that reduce disease burden in displacement, rural and urban crisis scenarios;
  2. estimate the cost and cost-effectiveness of these strategies; and
  3. quantify the global theoretical pneumococcal vaccine need for humanitarian uses

Expected Outcomes

The project is expected to have the following main outputs:

  1. A quantification of the absolute and relative/differential effect of PCV vaccination strategies in terms of cases averted, for each vaccination strategy considered, and in three model scenarios that we believe represent the main typologies of crisis that populations with high pneumococcal burden experience;
  2. A cost-effectiveness analysis of alternative vaccination strategies, based on the model outputs as in (1);
  3. Recommendations on optimal PCV vaccination strategies in a discrete set of generic crisis typologies, based on (1) and (2);
  4. A calculation of the annual doses of PCV required to best reduce burden of disease across current crises, based on (3), and of the approximate burden of pneumococcal disease avertable through vaccination or other interventions in crises.

Additional outputs will include:

  • A unique quantification of social mixing and nasopharyngeal carriage patterns in a displaced, overcrowded population, providing a basis for further work on disease control strategies in such populations, including for other pathogens;
  • A readily transferable, general model to estimate pneumococcal carriage, disease burden and the potential benefit of vaccination in other crisis settings, helping to tailor strategies and prioritisation decisions to specific contexts.

Publications

Peer Reviewed Disease (Communicable & Non-communicable)

Pneumococcal conjugate vaccine use during humanitarian crises

Article Disease (Communicable & Non-communicable)

Social contacts and other risk factors for respiratory infections among internally displaced people in Somaliland

Latest Updates

Study receives Gates Foundation funding

Oct 2021

The research team has received funding from the Bill and Melinda Gates Foundation to implement and evaluate the strategy identified as most effective by this R2HC funded study, to immunise internally displaced persons in humanitarian crisis settings.

View
2021Oct

World Pneumonia Day Campaign

12 Nov 2019

Kevin van Zandvoort participated in a televised campaign to raise local awareness for pneumonia and pneumococcal disease during world pneumonia day.

View
2019Nov

Logos

Subscribe to our newsletters....

Subscribe
 
Elrha © 2018 - 2021 Elrha is a registered charity in England and Wales (1177110). KEEP IN TOUCH Want to stay up to date with our latest updates? Sign up to our newsletters
Elrha
Elrha Please upgrade your browser

You are seeing this because you are using a browser that is not supported. The Elrha website is built using modern technology and standards. We recommend upgrading your browser with one of the following to properly view our website:

Windows Mac

Please note that this is not an exhaustive list of browsers. We also do not intend to recommend a particular manufacturer's browser over another's; only to suggest upgrading to a browser version that is compliant with current standards to give you the best and most secure browsing experience.